Gross profit · 2011–2025
Neogenomics gross profit
$314M+8.3% · FY2025
Neogenomics (NEO) reported $314M in gross profit for fiscal 2025, +8.3% year on year.
| Fiscal year | Gross profit | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $314M | +8.3% | Open → |
| FY20242024-12-31 | $290M | +18.6% | Open → |
| FY20232023-12-31 | $245M | +30.2% | Open → |
| FY20222022-12-31 | $188M | +0.4% | Open → |
| FY20212021-12-31 | $187M | +0.6% | Open → |
| FY20202020-12-31 | $186M | −5.6% | Open → |
| FY20192019-12-31 | $197M | +54.7% | Open → |
| FY20182018-12-31 | $127M | +24.8% | Open → |
| FY20172017-12-31 | $102M | +3.9% | Open → |
| FY20162016-12-31 | $98.1M | +124.2% | Open → |
| FY20152015-12-31 | $43.8M | +7.5% | Open → |
| FY20142014-12-31 | $40.7M | +28.3% | Open → |
| FY20132013-12-31 | $31.7M | +18.3% | Open → |
| FY20122012-12-31 | $26.8M | +38.1% | Open → |
| FY20112011-12-31 | $19.4M | — | Open → |
Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +22.0%
Gross profit at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neogenomics gross profit |url=https://companiesranked.com/en/company/neogenomics/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neogenomics gross profit. CompaniesRanked. https://companiesranked.com/en/company/neogenomics/gross-profitBibTeX
@misc{companiesranked-en-company-neogenomics-gross-profit-2026,
author = {{CompaniesRanked}},
title = {{Neogenomics gross profit}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neogenomics/gross-profit}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001077183-26-000010 · February 17, 2026
{{cite web |title=Neogenomics gross profit — 10-K (0001077183-26-000010) |url=https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.